(3 years, 5 months ago)
Lords ChamberMy Lords, I assure the noble Lord that global Britain means that we remain committed to helping the most vulnerable. The noble Lord, Lord Purvis, raised the issue of cholera, and we should acknowledge the role that British aid and support has played in ensuring that cholera treatment is delivered. That is why we have given the commitment to both CEPI and Gavi, in addition to the COVAX facility, for the current crisis. Providing support to the most vulnerable is high up the priority list of the G7 agenda.
My Lords, will the Minister get the department to look again at the money going to non-governmental organisations working in Yemen under incredible difficulties? There is a simple reason: they are more effective than anyone else at delivering help in the benighted situation faced there. I repeat that we really should not cut aid to Yemen, let alone to all the other countries. We really need to look at this again.
My Lords, as ever, I listen carefully to my noble friend, who has great insight on international development. I note the concerns she has previously aired to me directly as well as what she has said today. Her point about the important role that NGOs play in Yemen is at the forefront of our mind, although I am sure she would acknowledge that things have been extremely challenging on the ground, particularly in some of the areas controlled by the Houthis.
(3 years, 7 months ago)
Lords ChamberMy Lords, the most reverend Primate makes some very pertinent and important points. On the issue of countries which have oversubscribed, some countries have already announced plans for that. We are not in that position, but others have announced how they will look at distribution. We would implore them to consider that the most equitable way to support that distribution is through the COVAX Facility and the AMC, for the very reasons that have been put forward; namely, that they have the most effective infrastructure and networks to allow for equitable and fast distribution of the vaccine as it is rolled out.
I take fully the most reverend Primate’s point on misinformation. At a time when people are concerned and worried, it is highly regrettable that some in the world are putting out misinformation on vaccines which have already gone through all stages of testing and have been approved. We must come together to tackle that and provide proper information.
The most reverend Primate’s point on logistics was well made. As vaccine distribution continues, we will work through our networks within the FCDO and the UN to further strengthen NGOs; for example, with training and by ensuring that front-line healthcare workers in the field in developing parts of the world are vaccinated first.
I thank my noble friend for the assurances he has given the House about his department. Will he ensure that every effort is made to focus medical help to Africa on preventive vaccines, but not only against Covid-19? Can use be made of the Virtual Doctors organisation, which can assist in setting up a preventive system in African countries?
My Lords, I can give my noble friend that assurance. My right honourable friend the Foreign Secretary is currently on a visit to Africa, where issues concerning Covid-19 and the vaccine will be addressed directly, as they will be by the Minister for Africa. In her latter point, my noble friend also makes a practical suggestion about distribution. As more vaccines become readily available and distribution evolves, we will take this forward as part of our planning and share it with other partners as well.
(4 years, 6 months ago)
Lords ChamberMy Lords, my noble friend raises concerns on how Syria has been used to promote proxies who are acting within Syria, and concerns have been raised rightly about Iran’s role. I assure him that we continue to impress upon all those who are party to the conflict, and are clear that Russia has an important role to impress upon not just the Syrian regime but the Iranians, that the use of proxies within Syria is continuing the destabilisation not just in that country but in the wider region.
Is my noble friend able to tell the House what more can be done through the ICRC to help with the appalling situation faced by children and women heads of families in the Idlib area particularly, where literally the most vulnerable are the key targets for the Russian attacks?
My noble friend speaks with great insight on this. She mentioned the ICRC, and there are other agencies. We continue to impress on not just Turkey but other partners to ensure that the humanitarian corridors can be retained, sustained and strengthened. The regret, as I said very clearly in the last debate we had on this issue, is that two humanitarian corridors were closed down. That is why certain aid cannot reach the most vulnerable. But we will continue to impress on UN agencies, NGOs working in the region and, most importantly, those countries that have a stake in Syria and have an influence over all parties in Syria, whatever side they are on, to continue to allow humanitarian access to all parts of Syria, particularly to those who are impacted and most vulnerable.
(4 years, 7 months ago)
Lords ChamberAgain, I pay tribute to the most reverend Primate for his work in South Sudan. I know this is an area close to his heart. Let me assure him that we are working closely not just with the Government but with civil society to ensure that we keep on track, and that the peace agreement between the two countries remains intact. We are supporting civil society organisations as well; for example, the UK is funding and enabling the South Sudan Council of Churches to engage in mediation. That is an important part of the reconciliation process in South Sudan, and for that matter in Sudan as well.
Has the Minister opened discussions with those countries supplying troops to the United Nations forces, which, as he rightly said, failed to intervene as they should have done in the recent disputes?
We are very much engaged with the countries involved in that mission and will raise those concerns directly with them.